KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revvity (RVTY) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Revvity (RVTY) over the last 17 years, with Q3 2025 value amounting to $931.4 million.

  • Revvity's Cash & Equivalents fell 2426.39% to $931.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $931.4 million, marking a year-over-year decrease of 2426.39%. This contributed to the annual value of $1.2 billion for FY2024, which is 2740.29% up from last year.
  • As of Q3 2025, Revvity's Cash & Equivalents stood at $931.4 million, which was down 2426.39% from $991.8 million recorded in Q2 2025.
  • Over the past 5 years, Revvity's Cash & Equivalents peaked at $2.3 billion during Q2 2023, and registered a low of $345.9 million during Q3 2022.
  • For the 5-year period, Revvity's Cash & Equivalents averaged around $911.4 million, with its median value being $959.8 million (2021).
  • In the last 5 years, Revvity's Cash & Equivalents soared by 40640.75% in 2021 and then crashed by 5597.7% in 2024.
  • Over the past 5 years, Revvity's Cash & Equivalents (Quarter) stood at $472.4 million in 2021, then fell by 15.16% to $400.7 million in 2022, then skyrocketed by 127.87% to $913.2 million in 2023, then rose by 27.4% to $1.2 billion in 2024, then dropped by 19.94% to $931.4 million in 2025.
  • Its Cash & Equivalents was $931.4 million in Q3 2025, compared to $991.8 million in Q2 2025 and $1.1 billion in Q1 2025.